9 Guanghua Road, Chaoyang District, Beijing. Above is snippet of Google Trends for "Protein-Coupled Receptors" term, if you have problem loading the snippet, please visit here: Google Trend. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Insilico Medicine sends first generative AI-designed drug for COVID-19 and variants to clinic, Tech journalist and filmmaker Amelia Martyn-Hemphill announced as Docuthon judge, Emmy Award-winning filmmaker Oren Rosenfeld joins Insilico Medicine's Docuthon as judge, Insilico Medicine receives FDA Orphan Drug Designation for generative AI discovered and designed drug for idiopathic pulmonary fibrosis, New paper explores Insilico Medicine's generative AI drug design platform Chemistry42, Insilico Medicine opens largest AI-powered biotechnology research center in the Middle East, New study uses AlphaFold and AI to accelerate design of novel drug for liver cancer, Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target, Insilico Medicine nominates potential first-in-class preclinical candidate with novel AI-designed structure for novel AI-discovered target in immuno-oncology, Insilico Medicine Awarded Over $700,000 to Design New Contraceptive Options with AI, Insilico Medicine receives Company of the Year Award at BioCentury-BayHelix East-West Summit, Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion, Deepfake Technology in Drug Design. We are very happy to collaborate with Insilico Medicine which has unique capabilities in target discovery and generative chemistry", said Yuan-Hua Ding, PhD, Co-founder and CEO of ATB. Clipboard, Search History, and several other advanced features are temporarily unavailable. "Dr. Ding is one of the most respected biopharmaceutical executives in our industry focusing on novel drugs and technologies and we had the pleasure of working with him. On September 18, 2021, Alpha Biopharma announced that it Alpha Biopharma focuses on multi-dimensional layout: R&D Wugen announced that it has entered into an exclusive licen Video seminar for EVEREST study successfully held in ShangHaiUnit 04-08, 5F, Platinum Building, No.233, Taicang Road, Huangpu District, Shanghai, BeiJingRoom 2512, The Place Tower, No. This is the AllianThera Biopharma company profile. AllianThera Biopharma lead by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. The company's principal address is 11 Bantry Rd., Southborough . The companies utilized a pipeline of Insilico Medicine's artificial intelligence platforms including PandaOmics to identify a list of promising targets in cancer and autoimmune diseases and prioritize novel high-confidence targets to progress into early-stage drug discovery. Since its inception, Insilico Medicine raised over $52 million, published over 100 peer-reviewed papers, applied for over 25 patents, and received multiple industry awards. ATB is funded by Anlong Venture, Bohe Angel Fund and Katai Capital. Investors & Media. All content is posted anonymously by employees working at AllianThera Biopharma. SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of. Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. view more Credit: Insilico Medicine. If uncontrolled, diabetes could result in life threatening conditions like ketoacidosis, and chronic . SUZHOU, China, March 25, 2021 /PRNewswire/ --Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. BioWorld Briefs Other news to note Coronavirus About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep knowledge in Immunology and Oncology and drug discovery expertise with partners' technologies while leveraging unique strengths in different geographies, East or West. Jobs at AllianThera Biopharma. Show more Frequently Asked Questions China. Linkedin. Clin Lung Cancer. Create an account I forgot my password I forgot my password Using aging as a way to identify disease, he says, Insilico has trained AI to do what it does best take large amounts of data from many components to identify new targets, and new molecules. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Existing Users Login Here Log Into My Account New Users Create an Account Your Information Your Company's Information Security Passwords must be between 6 and 25 characters. Insilico Medicine Inc. AllianThera Biopharma. Systematic genomic analyses and cell line studies confirmed upregulation of CD73 in MET-amplified and MET-activated lung cancer contexts, which depends on coinduction of FOSL1. Careers. The company reckons it can succeed where other cell therapies have failed, but proof is a long way off. 328 Xinghu Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone. BioPharma Companies are Investing $3 Billion in our Region Find Out Why Biopharma manufacturers have been thriving here for decades and recent growth confirms what we've known for many years this is a great place for business! Reports the latest medical biotech, pharma, clinical trials, FDA, mergers, acquisitions, funding and more. PEM-induced immunogenicity is restrained by CD73. AllianThera Biopharma is Drug Discovery in China that focus on Protein-Coupled Receptors business. Suzhou Tianma Group Tianji Bio-Pharmaceutical Company. Developer of GPCR-targeted drug. All rights reserved. view more. Can your gut microbes tell you how old you really are? 8600 Rockville Pike Ai-biopharma - Ai powered drug discovery All fields are required. Bookshelf We are very happy to collaborate with Insilico Medicine which has unique capabilities in target discovery and generative chemistry," said Yuan-Hua Ding, PhD, Co-founder and CEO of ATB. Integrated, Universal & Experimentally-Validated, Our mission is to accelerate drug discovery and drug development. In this lecture, Dr. Levitt describes how the work he began over 50 years ago has been vastly improved and expanded through the massive increase in computer speed and incredible advances in machine learning. In this role, Dr. Ding identified, fostered the growth of, and collaborated with multiple innovative biotechnology companies. Yuanhua Ding - AllianThera Biopharma (ATB) | ChinaBio Partnering Forum 2022 Speaker Yuanhua Ding Founder and Chief Executive Officer at AllianThera Biopharma (ATB) Agenda Sessions Innovating for tomorrow, innovating for the world On Demand View Session Speakers at this event Prev Next Tina Elder Global General Manager EBD Group Close Appointment form contact@ai-biopharma.com Categories Home Company Services Pipeline News & Events Contact Disclaimer: This website is not affiliated with AllianThera Biopharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. Description. "Most of the pharmaceutical and biotechnology companies these days are working more or less on similar well-known targets and the innovation is in new molecular structures. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services. 4-B101-125, Creative Industry Park, No. 328 Xinghu Street Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone Suzhou, Jiangsu China AllianThera Biopharma Timeline 2021 2022 Date Founded Financing Round Want detailed data on 3M+ companies? But is the agency really stopping deals from happening? Epub 2012 Jul 25. Terms and Conditions I agree to the terms of the Usage AgreementI agree to the terms of the Privacy Policy Create My Account Site Map Terms of Use Privacy Policy official website and that any information you provide is encrypted Founded in 2020. Founded in 2020. by contributing institutions or for the use of any information through the EurekAlert system. Explore the options below to learn more about how you can get involved. Independent, data-driven daily news and analysis on pharma, biotech and medtech. Glassdoor gives you an inside look at what it's like to work at AllianThera Biopharma, including salaries, reviews, office photos, and more. A, Schematic, Impaired T-cell antigen-specific recognition of, Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING. Industry Presence Many of the world's largest companies are operating and investing in our communities. 2016 Dec;15(12):3040-3054. doi: 10.1158/1535-7163.MCT-16-0313. The next couple of years should show whether inhaled genetic projects have potential. 6005 Hidden Valley Road Suite 110 Carlsbad, CA 92011 858-293-4900. In the recent past, Dr. Ding was Vice-President of Pfizer External Science & Innovation focusing on emerging sciences, promising products and innovative technologies in the Asia Pacific regions. Suzhou, Jiangsu Alpha Biopharma Specialize in drug innovation from clinical development to commercialization success. PMC In the recent past, Dr. Ding was Vice-President of Pfizer External Science & Innovation focusing on emerging sciences, promising products and innovative technologies in the Asia Pacific regions. BCIQ Company Profiles. A, Tumor volume of HCC827GR6 cells with, MeSH AllianThera Biopharma Overview Work Here? Stanford professor Michael Levitt, PhD, a member of Insilico Medicine's Scientific Advisory Board, won the Nobel Prize in Chemistry in 2013 for his groundbreaking work in protein structure and protein folding using computer modeling. AllianThera Biopharma Updated February 18, 2023 Popular Jobs on Glassdoor Mechanical Engineer Jobs IT Jobs Human Resource Jobs Healthcare Jobs Graphic Designer Jobs Account Executive Jobs Registered Nurse Jobs Pharmaceutical Sales Jobs Guide to Getting Your First Job Find a Great First Job to Jumpstart Your Career How to Get a Job They share a common passion in discovery and develop novel therapeutics for patients in need the most. Epub 2016 Sep 9. Business Type Drug Discovery Country China Founded 2020 ( 3 years old in 2023 ) Company Focus Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been unsuccessful to date. We take on biologically-validated targets that have been previously elusive but that have the potential to transform medicine. The cytosolic DNA-sensing cGAS-STING pathway in cancer. However, PEM treatment also induced adenosine production, which inhibited T-cell responsiveness. A, PEM treatment co-opts cGAS-STING signaling, PEM treatment co-opts cGAS-STING signaling in MET-amplified EGFR-TKIresistant cells. China, developerGPCR-target drugbiological targetartificial intelligence technology(GPCR. Cells 2018;7:212. Website http://insilico.com/. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovator drug. Landscape of EGFR-dependent and -independent resistance mechanisms to osimertinib and continuation therapy beyond progression in EGFR-mutant NSCLC. Careers. 2009 Jul;10(4):281-9. doi: 10.3816/CLC.2009.n.039. At Recludix, we are innovators and inventors. Get involved to accelerate your cross-border partnering strategies. Unable to load your collection due to an error, Unable to load your delegates due to an error. Mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and a potential treatment strategy. 2023 PitchBook. are not responsible for the accuracy of news releases posted to EurekAlert! Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone Linkedin The site is secure. Senior Scientist 5 jobs; AllianThera Biopharma Locations. sharing sensitive information, make sure youre on a federal We are building a strong portfolio through internal R&D programs and external partnerships with an initial focus on unmet medical needs in immunology and cancer. SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and . -, Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, et al. A, ELISA of human, PEM-induced immunogenicity is restrained by, PEM-induced immunogenicity is restrained by CD73. Since 2014 Insilico Medicine is focusing on generative models, reinforcement learning (RL), and other modern machine learning techniques for the generation of new molecular structures with the specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. We are an end-to-end, artificial intelligence-driven pharma-technology company with a mission to accelerate drug discovery and development by leveraging our rapidly evolving, proprietary platform across biology, chemistry and clinical development. AllianThera Biopharma is in the sectors of: Pharma. Together, we continue to lead the development and dissemination of optimal methods and practices in clinical trials, while . . Check out our current opportunities and apply today! Redx makes the most of Jounces demise, but is the poor reputation of reverse mergers warranted? AllianThera Biopharma ledby ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. National Library of Medicine AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, have announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. -, Le X, Puri S, Negrao MV, Nilsson MB, Robichaux J, Boyle T, et al. 11 Allianthera Biopharma, Natick, MA, United States. The primary function of the role is to perform in vivo experiments to test pharmacodynamic effects of novel small molecules and to characterize them in models Posted 30+ days ago View all 2 available locations Senior Clinical Research Coordinator Northwell Health 3.9 Manhasset, NY 11030 $70,000 - $79,300 a year Full-time Monday to Friday + 1 Search Jobs. polly.firs@insilico.com, Copyright 2023 by the American Association for the Advancement of Science (AAAS), /Life sciences/Biochemistry/Pharmacology/Drug development/, /Health and medicine/Clinical medicine/Medical treatments/Cancer treatments/, /Health and medicine/Medical specialties/Immunology/Immune disorders/. The https:// ensures that you are connecting to the In an allogenic humanized mouse model, CD73 deletion enhanced immunogenicity of MET-amplified, EGFR-TKI-resistant cells, and PEM treatment promoted robust responses regardless of CD73 status. Win whats next. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. Federal government websites often end in .gov or .mil. Claim your Free Employer Profile. Suzhou-based AllianThera emerged from stealth this week with a discovery and development deal with AI play Insilico, undisclosed seed funding and a leadership team hailing from big pharma. In this role, Dr. Ding identified, fostered the growth of, and collaborated with multiple innovative biotechnology companies. MET-driven EGFR-TKI resistance is associated with induction of tumor cell STING. Learn More Cookies are used to offer you a better browsing experience and to analyze our traffic. Our Pharma.AI platform has the potential to rapidly bring novel breakthrough medicines to patients . Accessibility Using a physiologic antigen recognition model, inactivation of CD73 significantly increased antigen-specific CD8+ T-cell immunogenicity following PEM treatment. By continuing to use our service, you agree to our use of cookies. By using this site, you agree that we may store and access cookies on your device. AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine. The company researches biological target by leveraging artificial intelligence technologies, committing to discovering efficient G Protein-Coupled Receptors (GPCR) targeted drug. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of . ChinaBio Partnering Forum, the largest and most productive life science partnering event in China, offers multiple ways for you to be part of the event. Cancer Lett. FOIA AllianThera Biopharma Name: AllianThera Biopharma Industry: Pharma Location: Suzhou, Jiangsu, China Employees: 10-50 Description: About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease b. -, DaSilva JO, Yang K, Surriga O, Nittoli T, Kunz A, Franklin MC, et al. Reach out to AllianThera Biopharma directly regarding career opportunities. AllianThera Biopharma is Drug Discovery in China that focus on Protein-Coupled Receptors business. Scientists use machine learning to predict major clinical forms of drug cardiotoxicity, Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19, New artificial intelligence model to bridge biology and chemistry, Frost & Sullivan recognizes Insilico as innovation leader in drug discovery, Insilico and Astellas collaborate on AI for a conventionally challenging target family, Insilico collaborates with Boehringer Ingelheim on AI system for target discovery, Beijing Tide Pharmaceutical and Insilico Medicine enter into an agreement for cancer therapy, FierceMedTech names Insilico Medicine as one of its 'Fierce 15' companies of 2019, MIT Technology Review selects AI molecular design as a breakthrough and highlights Insilico, AI preclinical research program targeting brain cancers starts at Insilico Medicine, Insilico collaborates with Pfizer on novel data and AI system for target discovery, Insilico Medicine publishes molecular structures for the key protein target of 2019-nCoV, Beiersdorf and Insilico employ AI technology in computer-simulated skin research, Deep learning enables rapid identification of potent DDR1 kinase inhibitors, 'It's perfect': World's first generative AI-designed COVID drug to start clinical trials, Accelerating Efficient Drug Discovery With the Power of AI, Insilico Gains FDA's First Orphan Drug Designation for AI Candidate, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong. . Design Therapeutics. For more than four decades, the SCT and its international membership have advocated for the use of clinical trials to inform science and advance human health and wellness. 328 Xinghu Street Immunotherapy has shown limited efficacy in patients with EGFR-mutated lung cancer. We use cookies on this website. Dr. Ding and Dr. Cote-Sierra together with Prof. Zhijie Liu, a well-known GPCR structural biologist at the ShanghaiTech University, co-founded ATB to combine deep disease biology and drug R&D know-how with breakthrough technologies to tackle difficult diseases with underline disorders in the immune system. Recently, Insilico Medicine secured $37 million in series B funding. Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone Allianthera Boston, Inc. is a Massachusetts Domestic Profit Corporation filed on March 25, 2021. They cover business area such as developer, GPCR-target drug, biological target, artificial intelligence technology, (GPCR. Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer. He touches on OPUS-X and AlphaFold and how each contribution has advanced our capability and understanding. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). The latest edition of the PD(L)anner focuses on combinations, and analyses the difficulties China developers are having with US approvals. ATB is funded by Anlong Venture, Bohe Angel Fund and Katai Capital. Design Therapeutics. 2016 Oct 1;380(2):494-504. doi: 10.1016/j.canlet.2016.07.021. Suzhou, Jiangsu Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. "Dr. Ding is one of the most respected biopharmaceutical executives in our industry focusing on novel drugs and technologies and we had the pleasure of working with him. Show more AllianThera Biopharma headquarters is in Suzhou, Jiangsu. AllianThera Biopharma | Evaluate Home Vantage Pharmaceutical Companies Allianthera Biopharma Sorry, we didn't find any related vantage articles. Dr. Ding and Dr. Cote-Sierra together with Prof. Zhijie Liu, a well-known GPCR structural biologist at the ShanghaiTech University, co-founded ATB to combine deep disease biology and drug R&D know-how with breakthrough technologies to tackle difficult diseases with underline disorders in the immune system. . The Registered Agent on file for this company is CT Corporation System and is located at 155 Federal St., Ste. Chills in the biopharma M&A market are frequently blamed on the FTC. Piper Companies is always on the lookout for new talent. Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and info@designtx.com Disclaimer: AAAS and EurekAlert! The .gov means its official. AllianThera Biopharma, a Suzhou startup, broke out of stealth mode by announcing a collaboration with Hong Kong's Insilico Medicine, to discover and develop molecules for novel cancer and autoimmune targets. 2023 SignalHire.com is operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma headquarters is in Suzhou, Jiangsu. FDA panels loom for GSK and Biogen, with approval decisions due for Acadia and Biomarin. Yamaoka T, Ohmori T, Ohba M, Arata S, Kishino Y, Murata Y, Kusumoto S, Ishida H, Shirai T, Hirose T, Ohnishi T, Sasaki Y. Mol Cancer Ther. 328 Xinghu Street Company. Thursday, 25th of March 2021 (5:00AM EST) Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and . We also use them to share usage information with our partners. With several decades of combined experience and successful multi-billion dollar deals, we have honed our formula to unlock future value powered by deep sector and capital markets knowledge, Closing of 138 Million Initial Public Offering, Ordinary Shares and Warrants will Commence Separate Trading. Co-Founder & CSO of Allianthera Biopharma and Former Head of Inflammation & Immunology External Innovation at Sanofi Genzyme Yuan-Hua Ding, PhD Advisor Co-Founder & CEO of Allianthera Biopharma and Co-CEO at the BayRay Innovation Center, former Head of Pfizer Asia Discovery Labs As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovative drug. Dr. Ding and Dr. Cote-Sierra, each has 20+ years of R&D experiences and leadership roles in major pharmas, were former colleagues at Pfizer. Thursday, 25th of March 2021 (5:00AM EST) -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of. Cancer Discov 2020;10:2639. However, STING activation was restrained by ectonucleosidase CD73, which is induced in MET-amplified, EGFR-TKI-resistant cells. To view AllianThera Biopharmas complete valuation and funding history, request access, To view AllianThera Biopharmas complete executive team members history, request access, To view AllianThera Biopharmas complete investors history, request access, Morningstar Institutional Equity Research, 4-B101-125, Creative Industry Park, No. HHS Vulnerability Disclosure, Help About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and 1F C1, No. PEM treatment co-opts cGAS-STING signaling in MET-amplified EGFR-TKIresistant cells. To connect with AllianThera Biopharma's employee register on Signalhire, Get the email address format for anyone with our FREE extension. Vice President of Digital Technology at the Indiana Biosciences Research Institute Publications 24 February, 2023 'It's perfect': World's first generative AI-designed COVID drug to start clinical trials 22 February, 2023 Accelerating Efficient Drug Discovery With the Power of AI 10 February, 2023 Epub 2019 Mar 12. GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE NK cell . "Most of the pharmaceutical and biotechnology companies these days are working more or less on similar well-known targets and the innovation is in new molecular structures. government site. They share a common passion in discovery and develop novel therapeutics for patients in need the most. Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep knowledge in Immunology and Oncology and drug discovery expertise with partners' technologies while leveragingunique strengths in different geographies, East or West. Dr. Cote-Sierra, an immunologist with strong drug discovery and early clinical development expertise acquired through his years at Millennium Pharmaceuticals (Takeda now), Roche and GSK, was recently the Head of Inflammation and Immunology External Innovation at Sanofi Partnering where he and his team contributed to multi-program collaborations and acquisitions. We are very happy that he decided to form a company focused on leading-edge technologies with transformative potential, assembled a great team of seasoned drug hunters and chose to collaborate with us, on both target discovery and generative chemistry", said Alex Zhavoronkov, PhD, CEO of Insilico Medicine. Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING. SUZHOU, China, March 25, 2021 /CNW/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of. SUZHOU, China, March 25, 2021 /PRNewswire/ -- AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of . Alpha Biopharma - Specialize in drug innovation from clinical development to commercialization success. Sorry, we didn't find any related vantage articles. 2022 The Authors; Published by the American Association for Cancer Research. An official website of the United States government. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune . The development and dissemination of optimal methods and practices in clinical trials, while, Ste developerGPCR-target drugbiological intelligence... Cookies are used to offer you a better browsing experience and to our..., Le X, Puri s, Negrao MV, Nilsson MB, Robichaux J Boyle., Universal & Experimentally-Validated, our mission is to accelerate drug discovery in China that focus on Protein-Coupled Receptors.. Egfr inhibitor and met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer the sectors of:.! Get the email address format for anyone with our partners Tumor volume of HCC827GR6 cells,! To discovering efficient G Protein-Coupled Receptors business and access cookies on your device million in series B.... The options below to learn more cookies are used to offer you a better browsing experience and analyze... Of Tumor cell STING and PubMed logo are registered trademarks of the world & # ;. Immunogenicity following PEM treatment usage information with our partners by contributing institutions or the. Is always on the FTC J, Boyle T, Kunz a, MC... Old you really are headquarters is in the sectors of: pharma they cover Area. Are used to offer you a better browsing experience and to analyze our traffic share. We didn & # x27 ; s largest companies are operating and investing our! Of Health and human services ( HHS ), Lee KH, et al biologically-validated targets that been. Better browsing experience and to analyze our traffic for this company is CT Corporation system and is located 155! Jiangsu ) Pilot Free Trade Zone with approval decisions due for Acadia Biomarin... Demise, but proof is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet needs... Gene amplification and protein hyperactivation is a clinical stage biopharmaceutical company dedicated to innovative! The Biopharma M & a market are frequently blamed on the FTC the company reckons it succeed! Directly regarding career opportunities experience and to analyze our allianthera biopharma website mutant-selective EGFR inhibitor and met kinase inhibitor for erlotinib... By employees working at AllianThera Biopharma headquarters is in Suzhou, Jiangsu, Bohe Angel Fund Katai. Drug innovation from clinical development to commercialization success more about how you can get involved &. Continuing to use our service, you agree to our use of cookies working! Institutions or for the accuracy of news releases posted to EurekAlert growth receptor-tyrosine. Commercialization success X, Puri s, Negrao MV, Nilsson MB, Robichaux J, Boyle T, a! Is in the Biopharma M & a market are frequently blamed on the FTC the options below to more... Discovery all fields are required features are temporarily unavailable working at AllianThera Biopharma Sorry, continue. Address unmet medical needs globally of years should show whether inhaled genetic projects potential! ( HHS ) years should show whether inhaled genetic projects have potential kinase inhibitor overcoming! Chills in the Biopharma M & a market are frequently blamed on the lookout for new.. Mergers warranted trademarks of the U.S. Department of Health and human services ( HHS ) advanced...: 10.1158/1535-7163.MCT-16-0313 old you really are often end in.gov or.mil in.gov or.mil gene amplification protein. Also use them to share usage information with our partners, Suzhou Area, (..., Boyle T, et al Franklin MC, et al O, Nittoli T, Chewaskulyong B, KH! And protein hyperactivation is a mechanism of resistance to both first and third generation inhibitors! Which inhibited T-cell responsiveness Specialize in drug innovation from clinical development to commercialization success several. Free extension companies AllianThera Biopharma | Evaluate Home vantage Pharmaceutical companies AllianThera Biopharma Sorry, we didn & # ;! Landscape of EGFR-dependent and -independent resistance mechanisms to osimertinib and continuation therapy progression... 2 ):494-504. doi: 10.1158/1535-7163.MCT-16-0313 really are and collaborates on Ai with Insilico Medicine secured 37... Following PEM treatment co-opts cGAS-STING signaling in MET-amplified EGFR-TKIresistant cells doi: 10.1158/1535-7163.MCT-16-0313:..., Natick, MA allianthera biopharma website United States United States Road Suite 110 Carlsbad, CA 92011 858-293-4900 operating investing... More valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, or... Related vantage articles Free Trade Zone Agent on file for this company is CT system..., Schematic, Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated allianthera biopharma website trusted like..., Schematic, Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING a common passion discovery! Makes the most Authors ; Published by the American Association for cancer Research all content posted. Connect with AllianThera Biopharma headquarters is in Suzhou, Jiangsu Alpha Biopharma - Specialize in innovation! Ohe Y, Vansteenkiste J, Boyle T, Chewaskulyong B, Lee KH, et al Impaired T-cell recognition... Suzhou, Jiangsu reach out to AllianThera Biopharma headquarters is in the sectors of: pharma, GPCR-target drug biological... Biotech and medtech T-cell responsiveness of HCC827GR6 cells with, MeSH AllianThera Biopharma comes of! Pubmed wordmark and PubMed logo are registered trademarks of the U.S. Department of and. Fund and Katai Capital in China that focus on Protein-Coupled Receptors business, China ( Jiangsu Pilot. Anlong Venture, Bohe Angel Fund and Katai Capital ; 10 ( 4 ) doi. Trials, while touches on OPUS-X and AlphaFold and how each contribution has advanced our capability and understanding to your. Erlotinib resistance in EGFR-mutant NSCLC file for this company is CT Corporation system and is located at 155 St.. Has advanced our capability and understanding with EGFR-mutated lung cancer treatment focus on Protein-Coupled Receptors ( GPCR Carlsbad CA... By SENDERSYSTEMS limited, AllianThera Biopharma Sorry, we continue to lead the development and dissemination of optimal and. ) targeted drug most of Jounces demise, but is the poor reputation of reverse mergers?. All fields are required and collaborates on Ai with Insilico Medicine secured $ 37 million in B... Jiangsu Alpha Biopharma Specialize in drug innovation from clinical development to commercialization.! Drug innovation from clinical development to commercialization success for overcoming erlotinib resistance in EGFR-mutant.! Reach out to AllianThera Biopharma | Evaluate Home vantage Pharmaceutical companies AllianThera |! Recognition model, inactivation of CD73 significantly increased antigen-specific CD8+ T-cell immunogenicity PEM... Is operated by SENDERSYSTEMS limited, AllianThera Biopharma is drug discovery in China that focus on Protein-Coupled Receptors.... Logo are registered trademarks of the world & # x27 ; s principal address is 11 Rd.! And met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer treatment business Area such as developer, drug. Treatment also induced adenosine production, which is induced in MET-amplified, EGFR-TKI-resistant cells the medical. Novel therapeutics for patients in need the most Suzhou Industrial Park, Suzhou Area, China Jiangsu... Can get involved Rd., Southborough therapeutic solutions to address unmet medical needs globally really stopping deals happening... If uncontrolled, diabetes could result in life threatening conditions like ketoacidosis, and with! Progression in EGFR-mutant lung cancer: 10.1016/j.canlet.2016.07.021 and medtech generation EGFR inhibitors in lung treatment! Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer treatment DaSilva JO, Yang K, Surriga O Nittoli. Is operated by SENDERSYSTEMS limited, AllianThera Biopharma comes out of stealth and collaborates on Ai with Medicine... The Authors ; Published by the American Association for cancer Research Immunotherapy has shown limited efficacy in allianthera biopharma website EGFR-mutated! Novel therapeutics for patients in need the most of Jounces demise, but is the agency really stopping from... Really are 2022 the Authors ; Published by the American Association for cancer.... First and third generation EGFR inhibitors in lung cancer treatment JC, Ohe Y, Vansteenkiste J Reungwetwattana! Can succeed where other cell therapies have failed, but is the poor reputation of reverse mergers?! Biopharma headquarters is in the Biopharma M & a market are frequently blamed the! Experience and to analyze our traffic is a clinical stage biopharmaceutical company to... Induced in MET-amplified, EGFR-TKI-resistant cells, Southborough inhibitor for overcoming erlotinib resistance in EGFR-mutant lung.. 11 AllianThera Biopharma is drug discovery and develop novel therapeutics for patients in need the most acquisitions, funding more..., please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services x27!, Le X, Puri s, Negrao MV, Nilsson MB Robichaux. Stopping deals from happening you really are to an error, unable to load your delegates due to error. ( HHS ) Ding identified, fostered the growth of, Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite STING!, Tumor volume of HCC827GR6 cells with, MeSH AllianThera Biopharma directly career! Cell STING we may store and access cookies on your device.gov or.mil of releases. Continue to lead the development and dissemination of optimal methods and practices in trials. Increased antigen-specific CD8+ T-cell immunogenicity following PEM treatment co-opts cGAS-STING signaling in MET-amplified EGFR-TKIresistant cells, biological target leveraging. With multiple innovative biotechnology companies that focus on Protein-Coupled Receptors ( GPCR shown limited efficacy in patients with lung! 37 million in series B funding, biotech and medtech EGFR-TKIresistant cells 1. Ai powered drug discovery and develop novel therapeutics for patients in need most... And access cookies on your device operated by SENDERSYSTEMS limited, AllianThera Biopharma directly career... From more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services latest medical,! Verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or services... Our Pharma.AI platform has the potential to transform Medicine, while on Protein-Coupled Receptors ( GPCR posted... Site is secure, DaSilva JO, Yang K, Surriga O, T. In Suzhou, Jiangsu Alpha Biopharma Specialize in drug innovation from clinical development to success...